董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Quentin Koffey | -- | Vice Chairman of the Board | -- | 未披露 | 未持股 | 2025-08-18 |
| Catherine M. Szyman | -- | Chief Executive Officer and Director | -- | 未披露 | 未持股 | 2025-08-18 |
| Michelle M. Brennan | -- | Chairman of the Board | -- | 未披露 | 未持股 | 2025-08-18 |
| Wendy E. Lane | -- | Independent Director | -- | 未披露 | 未持股 | 2025-08-18 |
| Timothy John Scannell | -- | Independent Director | -- | 未披露 | 未持股 | 2025-08-18 |
| Darlene J. S. Solomon | 女 | Independent Director | 66 | 未披露 | 未持股 | 2025-08-18 |
| Craig Reynolds | 男 | Independent Director | 76 | 7.37万美元 | 未持股 | 2025-08-18 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Catherine M. Szyman | -- | Chief Executive Officer and Director | -- | 未披露 | 未持股 | 2025-08-18 |
| Paul Hataishi | -- | Senior Vice President and Chief Accounting Officer | -- | 未披露 | 未持股 | 2025-08-18 |
| Micah Young | -- | Executive Vice President and Chief Financial Officer | -- | 未披露 | 未持股 | 2025-08-18 |
| Blair Tripodi | -- | Chief Operating Officer, Consumer Division | -- | 未披露 | 未持股 | 2025-08-18 |
| Elisabeth A. Hellmann | -- | Chief Human Resources Officer | -- | 未披露 | 未持股 | 2025-08-18 |
| Tim Benner | -- | Chief Marketing Officer and Chief Strategy Officer | -- | 未披露 | 未持股 | 2025-08-18 |
| Huimin Wang | -- | President, Japan & Asia Pacific | -- | 未披露 | 未持股 | 2025-08-18 |
董事简历
中英对照 | 中文 | 英文- Quentin Koffey
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Catherine M. Szyman
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Michelle M. Brennan
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Wendy E. Lane
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Timothy John Scannell
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Darlene J. S. Solomon
-
Darlene J. S. Solomon，自2022年6月28日起担任公司董事。她于2006年至2023年7月期间担任生命科学、诊断和应用化学品市场的全球领导者安捷伦科技公司的高级副总裁兼首席技术官。2006年之前，所罗门博士曾担任安捷伦的集中式高级研究机构——安捷伦实验室的副总裁兼董事。她于1999年加入安捷伦，曾担任生命科学技术实验室主任和安捷伦生命科学和化学分析业务研发/技术高级总监的双重职务。她在斯坦福大学获得化学学士学位，在麻省理工学院获得无机化学博士学位。所罗门博士是美国国家工程院的成员，在多个专注于科学、技术和创新的学术和政府顾问委员会任职。Solomon博士还自2011年起担任先进材料领军企业Materion Corporation的董事会成员。
Darlene J. S. Solomon,served as Senior Vice President and Chief Technology Officer of Agilent Technologies, Inc. (life sciences, diagnostics and applied chemical markets) from 2006 until she retired from that position in July 2023. In addition to her leadership in organic research and development she is expert in open innovation, having developed and led Agilent's industry-leading, enterprise-wide academic collaboration and corporate venture programs. Prior to 2006, she served as Vice President and Director of Agilent Laboratories, Agilent's centralized advanced research organization. Dr. Solomon has served on the Board of Directors of Novanta Inc. since 2022 and she joined the board of Masimo Corporation in 2024. She is a member of the National Academy of Engineering and serves on multiple industry, academic and government advisory boards focused on science, technology, and innovation. - Darlene J. S. Solomon，自2022年6月28日起担任公司董事。她于2006年至2023年7月期间担任生命科学、诊断和应用化学品市场的全球领导者安捷伦科技公司的高级副总裁兼首席技术官。2006年之前，所罗门博士曾担任安捷伦的集中式高级研究机构——安捷伦实验室的副总裁兼董事。她于1999年加入安捷伦，曾担任生命科学技术实验室主任和安捷伦生命科学和化学分析业务研发/技术高级总监的双重职务。她在斯坦福大学获得化学学士学位，在麻省理工学院获得无机化学博士学位。所罗门博士是美国国家工程院的成员，在多个专注于科学、技术和创新的学术和政府顾问委员会任职。Solomon博士还自2011年起担任先进材料领军企业Materion Corporation的董事会成员。
- Darlene J. S. Solomon,served as Senior Vice President and Chief Technology Officer of Agilent Technologies, Inc. (life sciences, diagnostics and applied chemical markets) from 2006 until she retired from that position in July 2023. In addition to her leadership in organic research and development she is expert in open innovation, having developed and led Agilent's industry-leading, enterprise-wide academic collaboration and corporate venture programs. Prior to 2006, she served as Vice President and Director of Agilent Laboratories, Agilent's centralized advanced research organization. Dr. Solomon has served on the Board of Directors of Novanta Inc. since 2022 and she joined the board of Masimo Corporation in 2024. She is a member of the National Academy of Engineering and serves on multiple industry, academic and government advisory boards focused on science, technology, and innovation.
- Craig Reynolds
-
Craig Reynolds，自2010年8月起担任董事会成员。Reynolds先生曾于2011年1月至2017年2月担任Ebb Therapeutics（前身为Cereve Inc.）的首席执行官兼总裁。在加入EBB Therapeutics之前，Reynolds先生曾于2008年至2010年担任飞利浦Respironics家庭健康解决方案的首席运营官。在被飞利浦Respironics收购之前，Reynolds先生在1998年至2008年期间担任飞利浦Respironics的首席运营官和董事会成员。从1993年到1998年，Reynolds先生在医疗设备公司Healthdyne Technologies，Inc.任职，担任了五年的首席执行官和董事。他目前担任Masimo Corporation、EBB Therapeutics，Inc.和Zephyr，Inc.的董事会成员。2008年1月至2014年7月，Reynolds先生担任Symmetry Medical，Inc.的董事，并于2009年6月至2014年8月担任董事会主席。他还于2014年8月至2016年7月担任Symmetry Surgical公司董事会主席。Reynolds先生在乔治亚理工学院获得工业管理学士学位，在乔治亚州立大学获得市场营销硕士学位。
Craig Reynolds has served as a member of board since August 2010. Mr. Reynolds served as the Chief Executive Officer and President of Ebb Therapeutics formerly Cereve Inc. from January 2011 to February 2017. Prior to joining Ebb Therapeutics, Mr. Reynolds served as Chief Operating Officer of Philips Respironics Home Health Solutions from 2008 to 2010. Prior to its acquisition by Philips Respironics, Mr. Reynolds was the Chief Operating Officer and a board member of Philips Respironics from 1998 to 2008. From 1993 to 1998 Mr. Reynolds was with Healthdyne Technologies, Inc., a medical device company, serving for five years as Chief Executive Officer and Director. He currently serves as a board member of Masimo Corporation, Ebb Therapeutics, Inc. and Zephyr, Inc. From January 2008 through July 2014 Mr. Reynolds served as a director of Symmetry Medical, Inc., and as Chairman of the Board from June 2009 to August 2014. He also served as Chairman of the Board of Symmetry Surgical, Inc. from August 2014 through July 2016. Mr. Reynolds earned his BS in Industrial Management from the Georgia Institute of Technology and an MBA in marketing from Georgia State University. - Craig Reynolds，自2010年8月起担任董事会成员。Reynolds先生曾于2011年1月至2017年2月担任Ebb Therapeutics（前身为Cereve Inc.）的首席执行官兼总裁。在加入EBB Therapeutics之前，Reynolds先生曾于2008年至2010年担任飞利浦Respironics家庭健康解决方案的首席运营官。在被飞利浦Respironics收购之前，Reynolds先生在1998年至2008年期间担任飞利浦Respironics的首席运营官和董事会成员。从1993年到1998年，Reynolds先生在医疗设备公司Healthdyne Technologies，Inc.任职，担任了五年的首席执行官和董事。他目前担任Masimo Corporation、EBB Therapeutics，Inc.和Zephyr，Inc.的董事会成员。2008年1月至2014年7月，Reynolds先生担任Symmetry Medical，Inc.的董事，并于2009年6月至2014年8月担任董事会主席。他还于2014年8月至2016年7月担任Symmetry Surgical公司董事会主席。Reynolds先生在乔治亚理工学院获得工业管理学士学位，在乔治亚州立大学获得市场营销硕士学位。
- Craig Reynolds has served as a member of board since August 2010. Mr. Reynolds served as the Chief Executive Officer and President of Ebb Therapeutics formerly Cereve Inc. from January 2011 to February 2017. Prior to joining Ebb Therapeutics, Mr. Reynolds served as Chief Operating Officer of Philips Respironics Home Health Solutions from 2008 to 2010. Prior to its acquisition by Philips Respironics, Mr. Reynolds was the Chief Operating Officer and a board member of Philips Respironics from 1998 to 2008. From 1993 to 1998 Mr. Reynolds was with Healthdyne Technologies, Inc., a medical device company, serving for five years as Chief Executive Officer and Director. He currently serves as a board member of Masimo Corporation, Ebb Therapeutics, Inc. and Zephyr, Inc. From January 2008 through July 2014 Mr. Reynolds served as a director of Symmetry Medical, Inc., and as Chairman of the Board from June 2009 to August 2014. He also served as Chairman of the Board of Symmetry Surgical, Inc. from August 2014 through July 2016. Mr. Reynolds earned his BS in Industrial Management from the Georgia Institute of Technology and an MBA in marketing from Georgia State University.
高管简历
中英对照 | 中文 | 英文- Catherine M. Szyman
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Paul Hataishi
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Micah Young
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Blair Tripodi
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Elisabeth A. Hellmann
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Tim Benner
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Huimin Wang
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介